Importance of Indazole against Neurological Disorders.
Alzheimer disease
GSK-3
Indazole
LRRK-2
MAO
Neurological disorders
Parkinson's disease
Journal
Current topics in medicinal chemistry
ISSN: 1873-4294
Titre abrégé: Curr Top Med Chem
Pays: United Arab Emirates
ID NLM: 101119673
Informations de publication
Date de publication:
2022
2022
Historique:
received:
03
08
2021
revised:
05
12
2021
accepted:
27
12
2021
pubmed:
3
3
2022
medline:
19
8
2022
entrez:
2
3
2022
Statut:
ppublish
Résumé
Indazole is a nitrogen-containing bicyclic compound, having three tautomeric forms: 1Hindazole, 2H-indazole, and 3H-indazole. Mostly, they are considered as 1H-indazole tautomeric forms, although they have the potential to tautomerism to 2H- and 3H-indazole forms. Indazoles are involved in a wide variety of biological and enzymatic processes. Therefore, they exhibit a series of pharmacological activities. Indazoles show potent activities against neurological disorders such as Parkinson's disease (PD), Alzheimer's disease (AD), mood disorders, etc., by inhibiting different signaling pathways and the generation of neurotransmitters and activation of enzyme activity. They effectively prevent neurological diseases by different mechanisms, such as by inhibiting the monoamine oxidase (MAO) and kinase enzymes like Glycogen synthase kinase 3 (GSK3), and leucinerich repeat kinase enzyme 2 (LRRK2). In this article, we have discussed multiple causative strategies of indazole to treat neurological diseases. This has aroused special attention in the discovery of the novel indazoles and their biological activities.
Identifiants
pubmed: 35232360
pii: CTMC-EPUB-121163
doi: 10.2174/1568026622666220225152443
doi:
Substances chimiques
Indazoles
0
Monoamine Oxidase
EC 1.4.3.4
Glycogen Synthase Kinase 3
EC 2.7.11.26
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1136-1151Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.